Cancer progression involves the accumulation of genetic, epigenetic, metabolic, and environmental changes that allow abnormal cells to proliferate and survive.

Among the biological processes associated with cancer development, oxidative stress has received considerable attention.

Oxidative stress occurs when the generation of reactive oxygen species exceeds the capacity of cellular antioxidant systems.

Reactive oxygen species include molecules such as superoxide, hydrogen peroxide, and hydroxyl radicals.

Although these molecules are commonly associated with cellular damage, they also have important physiological functions.

At controlled concentrations, reactive oxygen species participate in intracellular signaling, adaptation to environmental changes, immune responses, and regulation of cellular proliferation.

Cancer cells often exist under conditions of increased oxidative stress.

Rapid proliferation increases metabolic demand, while mitochondrial abnormalities, inflammation, hypoxia, and oncogenic signaling can further increase reactive oxygen species production.

Despite this oxidative burden, cancer cells can survive by activating antioxidant defense systems.

This creates a complex relationship between oxidative stress and cancer.

Excessive reactive oxygen species can damage malignant cells, whereas moderate oxidative signaling can promote tumor progression.

Understanding this balance is therefore important for identifying molecular vulnerabilities that can be therapeutically exploited.

Reactive Oxygen Species in Cancer Biology

Reactive oxygen species are chemically reactive oxygen-containing molecules generated during normal cellular metabolism.

Major reactive oxygen species include superoxide anion, hydrogen peroxide, and hydroxyl radicals.

Mitochondrial electron transport is an important source of intracellular reactive oxygen species.

Additional sources include NADPH oxidases, peroxisomes, endoplasmic reticulum processes, inflammatory cells, and various enzymatic reactions.

Reactive oxygen species can modify proteins, lipids, and nucleic acids.

However, hydrogen peroxide can also act as a signaling molecule because it can reversibly modify specific protein residues.

This signaling function allows reactive oxygen species to influence pathways controlling proliferation and survival.

Sources of Oxidative Stress in Cancer

Several mechanisms contribute to increased reactive oxygen species production in malignant cells.

These include:

• Mitochondrial dysfunction;
• Increased metabolic activity;
• Chronic inflammation;
• Hypoxia and reoxygenation;
• NADPH oxidase activity;
• Oncogenic signaling;
• Endoplasmic reticulum stress; and
• Altered cellular metabolism.

The relative contribution of each source differs between tumor types and individual tumors.

Mitochondrial Dysfunction

Mitochondria are major regulators of cellular energy metabolism and redox balance.

Electron leakage from the mitochondrial respiratory chain can generate superoxide.

Cancer-associated mitochondrial abnormalities can alter electron transport and increase reactive oxygen species production.

Mitochondrial reactive oxygen species can subsequently influence nuclear signaling and gene expression.

They can also contribute to genomic instability and metabolic adaptation.

NADPH Oxidases

NADPH oxidases are specialized enzymes that generate reactive oxygen species.

Several NADPH oxidase family members have been implicated in cancer biology.

Their activity can increase intracellular reactive oxygen species and regulate signaling pathways involved in proliferation, migration, inflammation, and angiogenesis.

Increased NADPH oxidase activity may therefore contribute to malignant progression.

Oxidative DNA Damage

Reactive oxygen species can damage DNA through oxidation of nucleotide bases, strand breaks, and other molecular alterations.

One important oxidative DNA lesion is 8-oxo-7,8-dihydroguanine.

Accumulation of oxidative DNA damage can increase mutation rates and contribute to genomic instability.

Defects in DNA repair mechanisms can further increase the consequences of oxidative damage.

Oxidative Stress and Genomic Instability

Genomic instability is a major characteristic of cancer.

Reactive oxygen species can cause DNA lesions and interfere with chromosome integrity.

When oxidative damage is not adequately repaired, mutations can accumulate.

Some of these mutations may affect oncogenes or tumor-suppressor genes.

This can contribute to malignant transformation and tumor evolution.

Lipid Peroxidation

Reactive oxygen species can attack polyunsaturated fatty acids in cellular membranes.

This process, known as lipid peroxidation, produces reactive lipid-derived molecules.

These products can alter membrane structure and modify proteins and DNA.

Lipid peroxidation can also influence cell death pathways.

In some circumstances, excessive lipid peroxidation can promote ferroptosis, an iron-dependent form of regulated cell death.

Protein Oxidation

Reactive oxygen species can modify amino acid residues within proteins.

Oxidative modification can alter protein structure, enzymatic activity, localization, and stability.

Persistent protein oxidation can interfere with cellular metabolism and signaling.

Cancer cells therefore require efficient systems for maintaining protein redox balance.

Antioxidant Defense Mechanisms

Cells possess multiple antioxidant mechanisms to control reactive oxygen species.

These mechanisms include enzymatic and non-enzymatic antioxidants.

Major antioxidant systems include:

• Superoxide dismutases;
• Catalase;
• Glutathione;
• Glutathione peroxidases;
• Peroxiredoxins;
• Thioredoxin systems;
• Glutaredoxin systems; and
• NRF2-regulated antioxidant pathways.

These systems work together to prevent excessive oxidative damage.

Superoxide Dismutase

Superoxide dismutases convert superoxide into hydrogen peroxide.

This reaction represents an important first step in cellular antioxidant defense.

Different superoxide dismutase isoforms are localized in different cellular compartments.

By controlling superoxide levels, these enzymes influence both oxidative damage and redox signaling.

Changes in superoxide dismutase activity can affect tumor-cell survival.

Catalase

Catalase converts hydrogen peroxide into water and molecular oxygen.

It is particularly important for controlling hydrogen peroxide concentrations.

By limiting hydrogen peroxide accumulation, catalase can protect cells from oxidative injury.

Changes in catalase activity have been observed in different cancers, although their effects can vary according to tumor type and cellular context.

Glutathione System

Glutathione is one of the major intracellular antioxidants.

It exists primarily in reduced and oxidized forms.

Reduced glutathione can donate electrons to neutralize reactive molecules and maintain protein thiol groups in an appropriate redox state.

Cancer cells frequently increase glutathione synthesis or recycling to cope with elevated oxidative stress.

This adaptation can promote survival and resistance to treatment.

Glutathione Peroxidases

Glutathione peroxidases use reducing equivalents to detoxify hydrogen peroxide and lipid hydroperoxides.

These enzymes are important for controlling oxidative damage.

Some glutathione peroxidases also regulate lipid peroxidation and influence susceptibility to ferroptosis.

The glutathione–glutathione peroxidase system can therefore have important implications for cancer-cell survival.

Thioredoxin System

The thioredoxin system is another major component of cellular redox regulation.

Thioredoxin proteins maintain appropriate redox states of cellular proteins.

Thioredoxin reductases use NADPH to regenerate reduced thioredoxin.

In many tumors, increased activity of the thioredoxin system supports proliferation and survival under oxidative conditions.

Peroxiredoxins

Peroxiredoxins are important peroxide-scavenging enzymes.

They regulate hydrogen peroxide levels and participate in redox signaling.

Some cancer cells increase peroxiredoxin expression to protect against oxidative damage.

This may enhance tumor-cell survival under stressful conditions.

NRF2 Signaling

Nuclear factor erythroid 2-related factor 2 is a central regulator of antioxidant gene expression.

Under normal conditions, NRF2 is continuously regulated and degraded.

Oxidative or electrophilic stress can stabilize NRF2.

NRF2 can then accumulate in the nucleus and activate genes involved in antioxidant defense, detoxification, glutathione synthesis, and cellular metabolism.

Although this response is protective in normal cells, persistent NRF2 activation can provide cancer cells with an enhanced ability to tolerate oxidative stress.

NRF2 and Cancer Progression

Cancer cells with persistent NRF2 activity may develop increased antioxidant capacity.

This can support survival under conditions of metabolic stress and rapid proliferation.

Enhanced NRF2 signaling may also contribute to resistance against chemotherapy and radiotherapy.

Consequently, the NRF2 pathway represents an important connection between redox regulation and therapeutic resistance.

Oxidative Stress and Cellular Signaling

Reactive oxygen species can influence numerous signaling pathways.

They may affect protein kinases, phosphatases, transcription factors, and growth-factor signaling.

Controlled oxidative signaling can promote cellular proliferation.

However, excessive oxidative stress can disrupt signaling and cause cellular injury.

The biological effect therefore depends strongly on the intensity, duration, and cellular localization of oxidative stress.

Oxidative Stress and Cancer Cell Proliferation

Cancer cells frequently maintain higher reactive oxygen species levels than normal cells.

Moderate oxidative stress can activate pathways associated with proliferation and survival.

For example, reactive oxygen species can influence MAPK, PI3K–AKT, and other signaling systems.

These changes can increase cellular growth and adaptation.

However, if reactive oxygen species exceed the antioxidant capacity of the cell, proliferation can be inhibited and cell death can occur.

Oxidative Stress and Apoptosis

Excessive oxidative stress can activate apoptosis.

Mitochondrial damage can lead to changes in mitochondrial membrane integrity and activation of pro-apoptotic signaling.

Oxidative modification of proteins can further promote cellular dysfunction.

Cancer cells may avoid this outcome by increasing antioxidant capacity and suppressing apoptotic pathways.

Oxidative Stress and Autophagy

Autophagy allows cells to degrade and recycle damaged organelles and proteins.

Oxidative stress can activate autophagy as an adaptive response.

In cancer, autophagy can have both tumor-suppressive and tumor-promoting functions.

It may eliminate damaged cellular components during early tumor development but can also help established tumors survive nutrient deprivation and oxidative stress.

Oxidative Stress and Ferroptosis

Ferroptosis is a regulated form of cell death characterized by iron-dependent accumulation of lipid peroxides.

The cellular antioxidant systems involving glutathione and glutathione peroxidase 4 are important regulators of ferroptosis susceptibility.

Cancer cells that depend heavily on antioxidant defenses may become vulnerable when these systems are disrupted.

This has generated interest in ferroptosis as a potential therapeutic strategy.

Oxidative Stress and Tumor Microenvironment

The tumor microenvironment can influence redox balance.

Cancer-associated fibroblasts, immune cells, endothelial cells, and inflammatory mediators can contribute to oxidative conditions.

Tumor cells can also modify the metabolism of surrounding cells.

These interactions can influence antioxidant availability and redox signaling.

Inflammation and Oxidative Stress

Chronic inflammation can increase reactive oxygen species production.

Activated immune cells produce reactive oxygen and nitrogen species as part of host defense.

Persistent inflammation can therefore create oxidative conditions that promote DNA damage and tumor progression.

Inflammatory signaling can also interact with redox-sensitive transcription factors.

Hypoxia and Redox Regulation

Rapidly growing tumors frequently contain regions of low oxygen availability.

Hypoxia alters mitochondrial metabolism and can affect reactive oxygen species production.

Hypoxia-inducible factors regulate genes involved in metabolism, angiogenesis, and survival.

The interaction between hypoxia and oxidative stress can promote tumor adaptation.

Oxidative Stress and Metabolic Reprogramming

Cancer cells undergo extensive metabolic changes.

Alterations in glucose metabolism, mitochondrial function, lipid metabolism, and amino-acid utilization influence redox balance.

The availability of NADPH is particularly important because it provides reducing power for antioxidant systems.

Cancer cells can therefore reprogram metabolism to maintain antioxidant capacity while sustaining rapid growth.

Oxidative Stress and Cancer Stem Cells

Cancer stem-cell populations can exhibit distinctive metabolic and redox characteristics.

Some cancer stem cells maintain relatively low reactive oxygen species levels through enhanced antioxidant mechanisms.

This may protect them from oxidative damage caused by chemotherapy and radiotherapy.

Targeting redox regulation in these populations may therefore help reduce treatment resistance.

Oxidative Stress and Therapeutic Resistance

Anticancer therapies frequently rely partly on oxidative damage.

Radiotherapy generates reactive oxygen species, while several chemotherapeutic agents can increase oxidative stress.

Cancer cells with strong antioxidant systems may neutralize these effects.

Increased glutathione, thioredoxin, NRF2, and related mechanisms can therefore contribute to treatment resistance.

Chemotherapy and Redox Adaptation

Some cancer cells adapt to chemotherapy by increasing antioxidant capacity.

Enhanced glutathione metabolism can reduce oxidative damage caused by treatment.

Increased expression of detoxification enzymes may also decrease the effective concentration of reactive drug metabolites.

These adaptations can allow resistant cancer-cell populations to survive.

Radiotherapy and Antioxidant Defense

Radiotherapy causes direct and indirect DNA damage.

Reactive oxygen species generated during irradiation contribute to cellular injury.

Cancer cells with efficient antioxidant defenses may be better able to neutralize radiation-induced oxidative stress.

This can contribute to reduced radiosensitivity.

Therapeutic Targeting of Antioxidant Systems

Because cancer cells frequently depend on antioxidant pathways, these systems may represent therapeutic vulnerabilities.

Potential strategies include inhibition of:

• Glutathione synthesis;
• Glutathione-dependent enzymes;
• Thioredoxin metabolism;
• Thioredoxin reductase;
• NRF2-associated signaling; and
• Other redox-regulating pathways.

The objective is to selectively increase oxidative stress in malignant cells while minimizing toxicity to normal tissues.

Pro-Oxidant Therapeutic Strategies

An alternative approach is to increase reactive oxygen species beyond the tolerance threshold of cancer cells.

If oxidative damage exceeds the capacity of antioxidant defenses, malignant cells may undergo apoptosis, ferroptosis, or other forms of cell death.

This approach is based on the concept that cancer cells may have a narrower therapeutic window for additional oxidative stress.

Review Design

The present article was prepared as a narrative review examining the relationship between oxidative stress, antioxidant defense mechanisms, and cancer progression.

Literature Search

Relevant scientific literature was reviewed from biomedical databases and peer-reviewed scientific journals.

Search terms included combinations of:

“oxidative stress,” “reactive oxygen species,” “cancer progression,” “antioxidant defense,” “glutathione,” “thioredoxin,” “NRF2,” “superoxide dismutase,” “catalase,” “ferroptosis,” “redox signaling,” “tumor microenvironment,” “chemotherapy resistance,” and “radiotherapy resistance.”

Inclusion Criteria

Studies were considered relevant when they investigated:

• Reactive oxygen species in cancer;
• Antioxidant defense mechanisms;
• Redox signaling;
• Oxidative DNA damage;
• Cancer progression;
• Therapeutic resistance;
• Ferroptosis; or
• Redox-targeted cancer therapy.

Exclusion Criteria

Publications without substantial relevance to oxidative stress, antioxidant mechanisms, or cancer biology were excluded from the primary synthesis.

Data Synthesis

The available evidence was organized according to sources of oxidative stress, antioxidant defense pathways, effects on tumor biology, therapeutic resistance, and potential treatment strategies.

Results

The reviewed evidence indicates that oxidative stress has a dual role in cancer.

Moderate reactive oxygen species levels can support malignant proliferation, migration, survival, and adaptation.

Excessive oxidative stress can instead cause DNA damage, mitochondrial dysfunction, lipid peroxidation, protein oxidation, and cellular death.

Cancer cells frequently adapt to increased oxidative stress by enhancing antioxidant defenses.

The glutathione and thioredoxin systems, together with antioxidant enzymes such as superoxide dismutases, catalase, glutathione peroxidases, and peroxiredoxins, contribute to maintenance of redox balance.

NRF2 represents a major transcriptional regulator of antioxidant and detoxification responses.

Persistent activation of antioxidant pathways can protect cancer cells from oxidative damage and contribute to resistance against chemotherapy and radiotherapy.

At the same time, dependence on antioxidant systems can create vulnerabilities that may be exploited therapeutically.

Oxidative stress represents an important component of cancer biology.

Unlike normal cells, cancer cells frequently operate under elevated metabolic and oxidative stress.

This condition results from multiple interacting factors, including mitochondrial dysfunction, increased proliferation, inflammation, hypoxia, and oncogenic signaling.

The increased production of reactive oxygen species creates a potentially dangerous environment for cancer cells.

However, malignant cells can adapt by increasing antioxidant capacity.

This adaptation creates an important biological paradox.

Reactive oxygen species can promote cancer development at moderate concentrations while becoming cytotoxic at higher concentrations.

Cancer cells therefore need to maintain reactive oxygen species within a specific range.

This redox balance can support signaling without causing excessive cellular damage.

The antioxidant systems involved in maintaining this balance are therefore important determinants of tumor survival.

Glutathione represents one of the most important intracellular antioxidant systems.

Increased glutathione synthesis can provide cancer cells with greater capacity to neutralize reactive oxygen species.

The thioredoxin system provides another major source of redox protection.

Together, these systems allow malignant cells to maintain protein function and survive oxidative conditions.

NRF2 is particularly important because it coordinates expression of numerous antioxidant and detoxification genes.

While NRF2 activation is normally protective, constitutive pathway activation can provide cancer cells with a survival advantage.

This may be particularly important in tumors exposed to metabolic stress, hypoxia, and anticancer treatment.

Oxidative stress also contributes to genomic instability.

DNA damage generated by reactive oxygen species can increase mutation accumulation.

Over time, these alterations may affect oncogenes and tumor-suppressor genes and contribute to tumor evolution.

However, oxidative stress does not act independently of other cancer mechanisms.

It interacts with inflammation, metabolism, hypoxia, mitochondrial signaling, and the tumor microenvironment.

These interactions create a highly dynamic redox environment.

One of the most promising therapeutic concepts is to exploit the difference between normal and malignant cells.

Cancer cells may already be close to their maximum oxidative tolerance.

Increasing oxidative stress or weakening antioxidant defenses could therefore selectively affect malignant cells.

Ferroptosis provides an example of this strategy.

Because ferroptosis depends on accumulation of lipid peroxides, disrupting glutathione metabolism or glutathione peroxidase activity may increase susceptibility.

Nevertheless, therapeutic targeting of redox systems presents challenges.

Normal cells also depend on antioxidant pathways.

Systemic inhibition could therefore produce toxicity.

Future strategies should aim for tumor-specific targeting based on molecular characteristics and metabolic dependencies.

Therapeutic Perspectives

Redox biology provides several potential therapeutic opportunities.

One approach is inhibition of antioxidant pathways that are particularly important for tumor survival.

Another approach is increasing reactive oxygen species production to exceed the antioxidant capacity of malignant cells.

A third strategy is combining redox-modulating treatments with conventional therapies.

For example, weakening antioxidant defenses may increase sensitivity to chemotherapy or radiotherapy.

Ferroptosis-inducing strategies are also being investigated as potential approaches against tumors that are highly dependent on lipid antioxidant systems.

Precision medicine may help identify tumors with specific redox vulnerabilities.

Molecular analysis of glutathione metabolism, NRF2 activity, mitochondrial function, and lipid metabolism could potentially identify patients who may benefit from redox-targeted treatments.

Future Perspectives

Future research should focus on defining the precise redox state of individual tumors.

Reactive oxygen species are highly dynamic, and measurements from whole tumor tissues may not accurately represent the conditions within individual cancer-cell populations.

Single-cell and spatial technologies may help identify redox differences between malignant cells and surrounding stromal cells.

Another important research area is the relationship between redox regulation and cancer immunology.

Oxidative stress can influence immune-cell function and may affect responses to immunotherapy.

The development of tumor-selective antioxidant inhibitors and ferroptosis-based therapies may provide additional treatment options.

Combining these approaches with molecular biomarkers could improve patient selection and therapeutic effectiveness.

Oxidative stress is a central component of cancer progression and therapeutic response.

Reactive oxygen species can promote DNA damage, genomic instability, proliferation, migration, angiogenesis, and cellular adaptation.

At the same time, excessive oxidative stress can induce apoptosis, ferroptosis, and other forms of cancer-cell death.

Cancer cells survive this oxidative environment by activating antioxidant defense mechanisms involving glutathione, thioredoxin, superoxide dismutases, catalase, glutathione peroxidases, peroxiredoxins, and NRF2-dependent transcriptional programs.

These systems can support tumor growth and contribute to resistance against chemotherapy and radiotherapy.

The dependence of malignant cells on antioxidant defenses also creates potential therapeutic vulnerabilities.

Future research should focus on selectively disrupting tumor redox homeostasis while preserving normal-cell antioxidant capacity.

A better understanding of redox biology, combined with molecular profiling and precision medicine, may facilitate development of more effective strategies for preventing cancer progression and overcoming therapeutic resistance.

1. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radical Biology and Medicine. 2010;49:1603–1616.
2. Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nature Reviews Drug Discovery. 2013;12:931–947.
3. Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nature Reviews Drug Discovery. 2009;8:579–591.
4. Sies H, Jones DP. Reactive oxygen species as pleiotropic physiological signalling agents. Nature Reviews Molecular Cell Biology. 2020;21:363–383.
5. Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Current Biology. 2014;24:R453–R462.
6. Hayes JD, Dinkova-Kostova AT. The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends in Biochemical Sciences. 2014;39:199–218.
7. DeNicola GM, Karreth FA, Humpton TJ, et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and induces tumorigenesis. Nature. 2011;475:106–109.
8. Sporn MB, Liby KT. NRF2 and cancer: a double-edged sword. Nature Reviews Cancer. 2012;12:564–571.
9. Harris IS, DeNicola GM. The complex interplay between antioxidants and ROS in cancer. Nature Reviews Cancer. 2020;20:305–319.
10. Brigelius-Flohé R, Maiorino M. Glutathione peroxidases. Biochimica et Biophysica Acta. 2013;1830:3289–3303.
11. Lu SC. Glutathione synthesis. Biochimica et Biophysica Acta. 2013;1830:3143–3153.
12. Powis G, Kirkpatrick L. Thioredoxin signaling as a target for cancer therapy. Current Opinion in Pharmacology. 2007;7:392–397.
13. Hayes JD, Dinkova-Kostova AT, Tew KD. Oxidative stress in cancer. Cancer Cell. 2020;38:167–197.
14. Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060–1072.
15. Stockwell BR, Angeli JPF, Bayir H, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171:273–285.
16. Dixon SJ, Stockwell BR. The role of iron and reactive oxygen species in cell death. Nature Chemical Biology. 2014;10:9–17.
17. Sabharwal SS, Schumacker PT. Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? Nature Reviews Cancer. 2014;14:709–721.
18. Sullivan LB, Chandel NS. Mitochondrial reactive oxygen species and cancer. Cancer & Metabolism. 2014;2:17.
19. Toyokuni S. Role of iron in carcinogenesis: cancer as a ferrotoxic disease. Cancer Science. 2009;100:9–16.
20. Murphy MP. How mitochondria produce reactive oxygen species. Biochemical Journal. 2009;417:1–13.